Research directory

Clinical trials

Find trials by company, ticker, title or NCT ID.

Filters
Reset
1,647 trials match your filters.
TrialSponsorPhaseStatusPrimary completion
IDE196 (Darovasertib) in Combination With Crizotinib as First-line Therapy in Metastatic Uveal MelanomaNCT05987332IDEAYA BiosciencesPhase 2, Phase 3Active not recruiting2027-01-15Estimated
IMPACT TRIAL: Efficacy and Safety of Pemvidutide in Subjects With Nonalcoholic Steatohepatitis (NASH)NCT05989711ALTPhase 2Completed2025-11-25Actual
Safety and Tolerability of GTX-104 Compared with Oral Nimodipine in Patients with ASAHNCT05995405GRCEPhase 3Active not recruiting2024-12Estimated
A Study to Evaluate the Efficacy of Amniotic Suspension Allograft in Patients With Osteoarthritis of the KneeNCT06000410OrganogenesisPhase 3Completed2025-08-15Actual
A Study of REC-4881 in Participants With Cancers Which Have an AXIN1 or APC MutationNCT06005974RXRXPhase 2Terminated2025-02-24Actual
A Phase 3 Randomized, Masked, Controlled Trial to Evaluate Efficacy and Safety of Belzupacap Sarotalocan (AU-011) Treatment Compared to Sham Control in Subjects With Primary Indeterminate Lesions or Small Choroidal MelanomaNCT06007690Aura BiosciencesPhase 3Active not recruiting2027-11-15Estimated
A Study to Evaluate the Effects of ACI-7104.056 in Patients With Early Stages of Parkinson's DiseaseNCT06015841ACIUPhase 2Active not recruiting2028-01Estimated
OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast CancerNCT06016738OLMAPhase 3Active not recruiting2026-10-31Estimated
A Phase 2a Proof-of-Concept Trial of Bempikibart (ADX-914) for the Treatment of Severe Alopecia Areata (SIGNAL-AA)NCT06018428QTTBPhase 2Active not recruiting2026-06Estimated
A 2nd Generation E1/E2B/E3-Deleted Adenoviral COVID-19 Vaccine: The TCELL VACCINE TRIALNCT06022224IBRXPhase 2, Phase 3Terminated2022-06-23Actual
Study to Evaluate the Effects of Oral NMRA-335140 Versus Placebo in Participants With Major Depressive DisorderNCT06029426NMRAPhase 3Completed2024-12-03Actual
Study to Assess the Safety and Effectiveness of NMRA-335140-501NCT06029439NMRAPhase 3Terminated2026-08-17Actual
Study to Evaluate the Long-term Safety of Rusfertide (PTG-300) in Subjects With Polycythemia VeraNCT06033586PTGXPhase 3Active not recruiting2026-04-01Estimated
Descartes-08 for Patients With Systemic Lupus ErythematosusNCT06038474Cartesian TherapeuticsPhase 2Active not recruiting2026-12-01Estimated
A Study to Investigate the Prevention of COVID-19 WithVYD222 in Adults with Immune Compromise and in Participants Aged 12 Years or Older Who Are At Risk of Exposure to SARS-CoV-2NCT06039449IVVDPhase 3Completed2024-11-19Actual
A Study of Efficacy and Safety of Rosnilimab in Subjects with Moderate to Severe Rheumatoid Arthritis (RENOIR)NCT06041269ANABPhase 2Active not recruiting2024-11-29Estimated
Comparing Efficacy & Safety Of TNX-1300 To Placebo With UC For Treatment Of Acute Cocaine Intoxication In ED Subjects (CATALYST)NCT06045793Tonix Pharmaceuticals, Inc.Phase 2Terminated2025-04-21Actual
A Study to Assess Efficacy and Safety of LB54640 in Patients With Hypothalamic ObesityNCT06046443RYTMPhase 2Completed2026-02-09Actual
Efficacy and Safety of Patidegib Gel 2% for Preventing Basal Cell Carcinomas on the Face of Adults With Gorlin SyndromeNCT06050122SLGLPhase 3Completed2026-08-20Actual
A Study of Olverembatinib in Patients With Newly Diagnosed Ph+ ALL (POLARIS-1)NCT06051409Ascentage Pharma Group Inc.Phase 3Recruiting2027-12-31Estimated
Effect of an Exploratory Vehicle on Meibomian Gland Dysfunction in Patients With DemodexNCT06054217TARSPhase 2Unknown2024-06-15Estimated
A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious InfectionsNCT06056297X4 PharmaceuticalsPhase 3Recruiting2027-09Estimated
Study to Assess the Effects of Oral NMRA-335140 Versus Placebo in Participants With Major Depressive DisorderNCT06058013NMRAPhase 3Completed2026-05-06Actual
Study to Assess the Effects of Oral NMRA-335140 in Participants With Major Depressive DisorderNCT06058039NMRAPhase 3Completed2026-05-04Actual
A Study of Oral Tebipenem Pivoxil Hydrobromide (TBP-PI-HBr) Compared to Intravenous Imipenem-cilastatin in Participants With Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP)NCT06059846Spero TherapeuticsPhase 3Completed2025-01-27Actual
Travoprost Intraocular Implant in Conjunction With Cataract SurgeryNCT06061718Glaukos CorporationPhase 3Unknown2024-03-18Actual
N-803 and PD-L1 t-haNK Combined With Bevacizumab for Recurrent or Progressive GlioblastomaNCT06061809IBRXPhase 2Active not recruiting2029-12-31Estimated
Open-Label Extension of EDG-5506 in Participants With Becker Muscular DystrophyNCT06066580EWTXPhase 2Enrolling by invitation2031-02Estimated
VK2735 for Weight Management Phase 2NCT06068946VKTXPhase 2Completed2024-02-27Actual
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.NCT06072612BriaCell Therapeutics CorporationPhase 3Recruiting2027-12Estimated

Primary completion marks the end of data collection for the main study measures, not a results publication date.